ArticleTherapeutic advances in medical oncology2026
Gemcitabine/nab-paclitaxel plus S-1 combination compared with gemcitabine/nab-paclitaxel in advanced pancreatic ductal adenocarcinoma: a retrospective study.
Kuan-Yu Tseng et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.